Home
Gene
CD22

CD22

Engineered Antibody Glyco-Abs

Predicted to enable CD4 receptor binding activity; protein phosphatase binding activity; and sialic acid binding activity. Involved in B cell activation; negative regulation of B cell receptor signaling pathway; and regulation of endocytosis. Located in early endosome and recycling endosome.

Mouse IgG1, kappa Anti-CD22 Recombinant Antibody (MOB-1248z) (MOB-1248z)
- Species Reactivity: Human
- Type: Mouse IgG1, κ
- Application: IF, FC

Recombinant Anti-Human CD22 Antibody scFv Fragment (MOB-1248z-S(P))
- Derivation: Mouse
- Species Reactivity: Human
- Type: scFv
- Application: ELISA, WB, IF, FuncS

Recombinant Anti-Human CD22 Antibody Fab Fragment (MOB-1248z-F(E))
- Derivation: Mouse
- Species Reactivity: Human
- Type: Fab
- Application: IP, RIA, FuncS

Anti-Human CD22 Recombinant Antibody (Epratuzumab) (TAB-176)
- Derivation: Humanized (from mouse)
- Species Reactivity: Human
- Type: IgG1
- Application: IF, IP, Neut, FuncS, ELISA, FC, ICC

Humanized Anti-CD22 Recombinant Antibody (clone Pinatuzumab) (TAB-899)
- Derivation: Humanized (from mouse)
- Species Reactivity: Human
- Type: Humanized (from mouse) IgG1, κ
- Application: FC, IP, ELISA, Neut, FuncS, IF, ICC

Anti-Human CD22 Recombinant Antibody Fab Fragment(Bectumomab) (TAB-047-F(E))
- Derivation: Mouse
- Species Reactivity: Human
- Type: Fab' - G2a - kappa
- Application: ELISA, FC, IP, FuncS, IF, Neut, WB

Human Anti-CD22 Recombinant Antibody (TAB-1729CL) (TAB-1729CL)
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized IgG
- Application: IF, FC

Anti-Human CD22 Recombinant Antibody Fab Fragment (CD22.1) (TAB-1721CL-F(E))
- Type: Human antibody
- Application: ELISA, FC, FuncS

Human Anti-CD22 Recombinant Antibody; scFv Fragment (TAB-1725CL-S(P)) (TAB-1725CL-S(P))
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized scFv
- Application: Block, Cyt, ELISA, FuncS

Human Anti-CD22 Recombinant Antibody (TAB-001LC) (TAB-001LC)
- Derivation: Chimeric (mouse/human)
- Species Reactivity: Human
- Type: Chimeric antibody (mouse/human)
- Application: ELISA

Mouse Anti-CD22 Recombinant Antibody; scFv Fragment (TAB-1724CL-S(P)) (TAB-1724CL-S(P))
- Species Reactivity: Human
- Type: Mouse scFv
- Application: Inhib

Anti-Human CD22 Recombinant Antibody Fab Fragment (21F6) (TAB-1720CL-F(E))
- Derivation: Human
- Type: Fully human antibody

Anti-CD22 (clone 10F4v3)-MC-vc-PAB-MMAE ADC (ADC-230CL)
- Target: CD22
- Linker: MC-VC-PABC (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl)
- Drug: MMAE (Monomethyl auristatin E)

Anti-Human CD22 Recombinant Antibody (RFB4) (TAB-1728CL)
- Application: IF, FC

Mouse Anti-CD22 Recombinant Antibody; scFv Fragment (TAB-1723CL-S(P)) (TAB-1723CL-S(P))
- Species Reactivity: Human
- Type: Mouse scFv
- Application: Inhib

Anti-Human CD22 Recombinant Antibody Fab Fragment (4G6) (TAB-1719CL-F(E))
- Derivation: Human
- Type: Fully human antibody

Anti-CD22 (clone 10F4v1)-MC-MMAF ADC (ADC-229CL)
- Target: CD22
- Linker: Mc (maleimidocaproyl)
- Drug: MMAF (Monomethyl auristatin F)

Anti-Human CD22 Recombinant Antibody scFv Fragment (CD22.2) (TAB-1722CL-S(P))
- Type: Human antibody
- Application: ELISA, FC, FuncS

Anti-Human CD22 Recombinant Antibody Fab Fragment (23C6) (TAB-1718CL-F(E))
- Derivation: Human
- Type: Fully human antibody

Anti-CD22 (clone 10F4v3)-MC-vc-PAB-MMAE ADC (ADC-228CL)
- Target: CD22
- Linker: MC-VC-PABC (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl)
- Drug: MMAE (Monomethyl auristatin E)

Anti-Human CD22 Recombinant Antibody scFv Fragment (CD22.1) (TAB-1721CL-S(P))
- Type: Human antibody
- Application: ELISA, FC, FuncS

Human Anti-CD22 Recombinant Antibody (TAB-1725CL) (TAB-1725CL)
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized IgG
- Application: Block, Cyt, ELISA, FuncS

Anti-Human CD22 Recombinant Antibody Fab Fragment (16F7) (TAB-1717CL-F(E))
- Derivation: Human
- Type: Fully human antibody

Anti-CD22 (clone RFB4)-MC-vc-PAB-MMAE ADC (ADC-227CL)
- Target: CD22
- Linker: MC-VC-PABC (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl)
- Drug: MMAE (Monomethyl auristatin E)

Anti-Human CD22 Recombinant Antibody scFv Fragment (21F6) (TAB-1720CL-S(P))
- Derivation: Human
- Type: Fully human antibody

Human Anti-CD22 Recombinant Antibody (TAB-1724CL) (TAB-1724CL)
- Derivation: Chimeric (mouse/human)
- Species Reactivity: Human
- Type: Chimeric (mouse/human) IgG1, κ
- Application: Inhib

Anti-Human CD22 Recombinant Antibody Fab Fragment (19A3) (TAB-1716CL-F(E))
- Derivation: Human
- Type: Fully human antibody

Anti-CD22 (clone RFB4)-MC-MMAF ADC (ADC-226CL)
- Target: CD22
- Linker: Mc (maleimidocaproyl)
- Drug: MMAF (Monomethyl auristatin F)

Anti-Human CD22 Recombinant Antibody scFv Fragment (4G6) (TAB-1719CL-S(P))
- Derivation: Human
- Type: Fully human antibody

Anti-Human CD22 Recombinant Antibody (CD22.2) (TAB-1722CL)
- Type: Human antibody
- Application: ELISA, FC, FuncS

Anti-Human CD22 Recombinant Antibody Fab Fragment (12C5) (TAB-1715CL-F(E))
- Derivation: Human
- Type: Fully human antibody

Anti-CD22 (clone RFB4)-MC-vc-PAB-MMAF ADC (ADC-225CL)
- Target: CD22
- Linker: MC-VC-PABC (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl)
- Drug: MMAF (Monomethyl auristatin F)

Anti-Human CD22 Recombinant Antibody scFv Fragment (23C6) (TAB-1718CL-S(P))
- Derivation: Human
- Type: Fully human antibody

Anti-Human CD22 Recombinant Antibody (CD22.1) (TAB-1721CL)
- Type: Human antibody
- Application: ELISA, FC, FuncS

Mouse Anti-CD22 Recombinant Antibody; Fab Fragment (TAB-1714CL-F(E)) (TAB-1714CL-F(E))
- Derivation: Mouse
- Species Reactivity: Human
- Type: Mouse Fab
- Application: ELISA, WB

Anti-CD22 (clone RFB4)-SMCC-DM1 ADC (ADC-224CL)
- Target: CD22
- Linker: SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate)
- Drug: DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine)

Anti-Human CD22 Recombinant Antibody (21F6) (TAB-1720CL)
- Derivation: Human
- Type: Fully human antibody
- Application: ELISA

Anti-Human CD22 Recombinant Antibody scFv Fragment (16F7) (TAB-1717CL-S(P))
- Derivation: Human
- Type: Fully human antibody

Anti-Human CD22 Recombinant Antibody Fab Fragment (hLL2-Cys) (TAB-0197CL-F(E))
- Application: ELISA, In vivo

Anti-Human CD22 Recombinant Antibody (4G6) (TAB-1719CL)
- Derivation: Human
- Type: Fully human antibody
- Application: ELISA

Anti-Human CD22 Recombinant Antibody scFv Fragment (19A3) (TAB-1716CL-S(P))
- Derivation: Human
- Type: Fully human antibody

Anti-CD22 (clone 10F4)-SMCC-DM1 ADC (ADC-223CL)
- Target: CD22
- Linker: SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate)
- Drug: DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine)

Anti-Human CD22 Recombinant Antibody Fab Fragment (hLL2) (TAB-0196CL-F(E))
- Application: ELISA, In vivo

Anti-Human CD22 Recombinant Antibody (23C6) (TAB-1718CL)
- Derivation: Human
- Type: Fully human antibody
- Application: Cyt, FuncS

Anti-Human CD22 Recombinant Antibody scFv Fragment (12C5) (TAB-1715CL-S(P))
- Derivation: Human
- Type: Fully human antibody

Anti-CD22 (clone 10F4v3)-MC-vc-PAB-MMAE ADC (ADC-222CL)
- Target: CD22
- Linker: MC-VC-PABC (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl)
- Drug: MMAE (Monomethyl auristatin E)

Anti-Human CD22 Recombinant Antibody (16F7) (TAB-1717CL)
- Derivation: Human
- Type: Fully human antibody
- Application: Cyt, FuncS

Anti-Human CD22 Recombinant Antibody scFv Fragment (hLL2-Cys) (TAB-0197CL-S(P))
- Application: ELISA, In vivo

Mouse Anti-CD22 Recombinant Antibody; scFv Fragment (TAB-1714CL-S(P)) (TAB-1714CL-S(P))
- Derivation: Mouse
- Species Reactivity: Human
- Type: Mouse scFv
- Application: ELISA, WB

Anti-CD22 (clone 10F4v3)-SPP-DM1 ADC (ADC-221CL)
- Target: CD22
- Linker: SPP (N-succinimidyl-4-(2-pyridyldithio)pentanoate)
- Drug: DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine)

Anti-Human CD22 Recombinant Antibody (19A3) (TAB-1716CL)
- Derivation: Human
- Type: Fully human antibody
- Application: Cyt, FuncS

Anti-Human CD22 Recombinant Antibody scFv Fragment (hLL2) (TAB-0196CL-S(P))
- Application: ELISA, In vivo

Anti-CD22 (clone 10F4v3)-mc-MMAF ADC (ADC-196LZY)
- Target: CD22
- Linker: mc(maleimidocaproyl)
- Drug: MMAF (monomethyl auristatin F)

Anti-CD22 (clone 10F4v3)-MC-MMAF ADC (ADC-220CL)
- Target: CD22
- Linker: Mc (maleimidocaproyl)
- Drug: MMAF (Monomethyl auristatin F)

Anti-Human CD22 Recombinant Antibody (12C5) (TAB-1715CL)
- Derivation: Human
- Type: Fully human antibody
- Application: Cyt, FuncS

Anti-Human CD22 Recombinant Antibody (hLL2-Cys) (TAB-0197CL)
- Application: ELISA, In vivo

Anti-CD22 (clone 10F4v3)-mc-vc-PABC-MMAE ADC (ADC-195LZY)
- Target: CD22
- Linker: mc-VC-PABC(maleimidocaproyl valine-citrulline-p-aminobenzyl carbamoyl)
- Drug: MMAE (monomethyl auristatin E)

Anti-CD22 (clone 10F4v3)-SMCC-DM1 ADC (ADC-219CL)
- Target: CD22
- Linker: SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate)
- Drug: DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine)

Mouse Anti-CD22 Recombinant Antibody (TAB-1714CL) (TAB-1714CL)
- Derivation: Mouse
- Species Reactivity: Human
- Type: Mouse IgG
- Application: ELISA, WB

Anti-Human CD22 Recombinant Antibody (hLL2) (TAB-0196CL)
- Application: Inhib, Cyt, FC, WB

Anti-CD22 (clone 10F4v3)-MCC-DM1 ADC (ADC-194LZY)
- Target: CD22
- Linker: MCC(Maleimidomethyl cyclohexane-1-carboxylate)
- Drug: DM1(N2'-deacetyl-N2'-(3-mercapto-1-oxopropyl)-maytansine)

Anti-CD22 (clone 10F4v2)-MC-MMAF ADC (ADC-218CL)
- Target: CD22
- Linker: Mc (maleimidocaproyl)
- Drug: MMAF (Monomethyl auristatin F)

Anti-CD22 (CR011)-vc-MMAE ADC (RG7593) (ADC-L028)
- Target: CD22
- Linker: vc (valine-citrulline)
- Drug: MMAE (Monomethyl auristatin E)

Anti-CD22 (clone 10F4v3)-SPP-DM1 ADC (ADC-193LZY)
- Target: CD22
- Linker: SPP(N-succinimidyl-4-(2-pyridyldithio)pentanoate)
- Drug: DM1(N2'-deacetyl-N2'-(3-mercapto-1-oxopropyl)-maytansine)

Anti-CD22 (Inotuzumab)-calicheamicin ADC (CMC-544/inotuzumab ozogamicin) (ADC-L024)
- Target: CD22
- Linker: acetyl butyrate linker
- Drug: calicheamicin

Anti-CD22-mc-vc-PABc-MMAE ADC (ADC-033LZY)
- Target: CD22
- Linker: mc-VC-PABc(maleimidocaproyl valine-citrulline-p-aminobenzyl carbamoyl)
- Drug: MMAE (monomethyl auristatin E)

Anti-CD22 (clone HB22.7)-saporin ADC (ADC-154LZY)
- Target: CD22
- Drug: saporin

Anti-CD22 (clone 10F4v2)-SMCC-DM1 ADC (ADC-217CL)
- Target: CD22
- Linker: SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate)
- Drug: DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine)

Anti-CD22 (Pinatuzumab)-MC-VC-PABC-MMAE ADC (ADC-034LCT)
- Target: CD22
- Linker: MC-VC-PABC (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl)
- Drug: MMAE (Monomethyl auristatin E)

Anti-CD22 (clone hu10F4)-MCC-DM1 ADC (ADC-027LZY)
- Target: CD22
- Linker: MCC (4-(N-maleimidomethyl)cyclohexane-1-carboxylate)
- Drug: DM1(N2'-deacetyl-N2'-(3-mercapto-1-oxopropyl)-maytansine)

Anti-CD22-mc-vc-PABc-NMS249 ADC (ADC-097LZY)
- Target: CD22
- Linker: mc-VC-PABc (maleimidocaproyl valine-citrulline-p-aminobenzyl carbamoyl)
- Drug: NMS249

Anti-CD22-MCC-DM1 ADC (ADC-033LCT)
- Target: CD22
- Linker: mcc (Maleimidomethyl cyclohexane-1-carboxylate)
- Drug: DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine)

Anti-CD22 (clone 10F4v1)-SMCC-DM1 ADC (ADC-216CL)
- Target: CD22
- Linker: SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate)
- Drug: DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine)

Anti-CD22-AcBut-CalichDMH ADC (ADC-006LZY)
- Target: CD22
- Linker: AcBut (4-(4-acetylphenoxy)butanoic acid)
- Drug: CalichDMH

Anti-CD22 (Inotuzumab)-DIBO-doxorubicin ADC (ADC-037LCT)
- Target: CD22
- Linker: DIBO (dibenzylcyclooctynol)
- Drug: doxorubicin

Anti-CD22-MC-MMAF ADC (ADC-032LCT)
- Target: CD22
- Linker: Mc (maleimidocaproyl)
- Drug: MMAF (Monomethyl auristatin F)

Anti-CD22 (clone 7A2)-SMCC-DM1 ADC (ADC-215CL)
- Target: CD22
- Linker: SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate)
- Drug: DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine)

Anti-CD22 (clone G5/44)-AcBut-CalichDMH ADC (ADC-003LZY)
- Target: CD22
- Linker: AcBut (4-(4-acetylphenoxy)butanoic acid)
- Drug: CalichDMH

Anti-CD22 (Inotuzumab)-hydrazone-Calicheamicin ADC (ADC-036LCT)
- Target: CD22
- Linker: hydrazone
- Drug: Calicheamicin

Anti-CD22-CL2E-SN-38 ADC (ADC-031LCT)
- Target: CD22
- Linker: CL2E
- Drug: SN-38 (7-ethyl-10-hydroxycamptothecin)

Anti-CD22 (clone 5E8)-SMCC-DM1 ADC (ADC-214CL)
- Target: CD22
- Linker: SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate)
- Drug: DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine)

anti-CD22 immunotoxin RFB4 (scFv)-Sap (AGTO-L048S)
- Species Reactivity: Human
- Application: Cytotoxicity assay, Functional assay

Anti-CD22 immunotoxin RFB4 (IgG)-Sap (AGTO-G077S)
- Species Reactivity: Human
- Application: Cytotoxicity assay, Function study

Anti-CD22-CL2A-SN-38 ADC (ADC-030LCT)
- Target: CD22
- Linker: CL2A
- Drug: SN-38 (7-ethyl-10-hydroxycamptothecin)

Anti-CD22 (clone 10F4v3)-MC-vc-PAB-MMAE ADC (ADC-213CL)
- Target: CD22
- Linker: MC-VC-PABC (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl)
- Drug: MMAE (Monomethyl auristatin E)

anti-CD22 immunotoxin RFB4 (scFv)-RTA (AGTO-L048R)
- Species Reactivity: Human
- Application: Cytotoxicity assay, Functional assay

Anti-CD22 immunotoxin RFB4 (IgG)-RTA (AGTO-G077R)
- Species Reactivity: Human
- Application: Cytotoxicity assay, Function study

Anti-CD22 (10F4)-AcBut-Calicheamicin ADC (ADC-029LCT)
- Target: CD22
- Linker: AcBut
- Drug: Calicheamicin

Anti-CD22 (clone 10F4v3)-MC-MMAF ADC (ADC-212CL)
- Target: CD22
- Linker: Mc (maleimidocaproyl)
- Drug: MMAF (Monomethyl auristatin F)

anti-CD22 immunotoxin RFB4 (scFv)-Gel (AGTO-L048G)
- Species Reactivity: Human
- Application: Cytotoxicity assay, Functional assay

Anti-CD22 immunotoxin RFB4 (IgG)-Gel (AGTO-G077G)
- Species Reactivity: Human
- Application: Cytotoxicity assay, Function study

Anti-CD22 (RFB4)-mcc-DM1 ADC (ADC-028LCT)
- Target: CD22
- Linker: mcc (Maleimidomethyl cyclohexane-1-carboxylate)
- Drug: DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine)

Anti-CD22 (clone 10F4v3)-BMPEO-DM1 ADC (ADC-211CL)
- Target: CD22
- Linker: BMPEO (bis-maleimido-trioxyethylene glycol)
- Drug: DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine)

anti-CD22 immunotoxin RFB4 (scFv)-DT (AGTO-L048D)
- Species Reactivity: Human
- Application: Cytotoxicity assay, Functional assay

Anti-CD22 immunotoxin RFB4 (IgG)-DT (AGTO-G077D)
- Species Reactivity: Human
- Application: Cytotoxicity assay, Function study

Anti-CD22 (clone hLL2)-SN-38 ADC (ADC-124CL)
- Target: CD22
- Drug: SN-38 (7-ethyl-10-hydroxycamptothecin)

Humanized Anti-CD22 Recombinant Antibody (clone Inotuzumab) (TAB-198)
- Derivation: Humanized (from mouse)
- Species Reactivity: Human
- Type: Humanized (from mouse) IgG4, κ
- Application: ELISA, FC, IP, FuncS, IF, Neut, ICC

anti-CD22 immunotoxin RFB4 (scFv)-PE (AGTO-L048E)
- Species Reactivity: Human
- Application: Cytotoxicity assay, Functional assay

Anti-CD22 immunotoxin RFB4 (IgG)-PE (AGTO-G077E)
- Species Reactivity: Human
- Application: Cytotoxicity assay, Function study

Anti-Human CD22 Recombinant Antibody (Moxetumomab Pasudotox) (TAB-183-F(E))
- Derivation: Mouse
- Species Reactivity: Human
- Type: Fv - disulfide stabilized
- Application: FuncS, IF, Neut, ELISA, FC, IP, ICC

Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us

Can't find the products you're looking for? Try to filter in the left sidebar.Filter By Tag

For Research Use Only. Not For Clinical Use.

Cart

Inquiry

Go to compare